Skip to content

Schizophrenia Gets an App and Your Dog Is Losing Sleep

October 16, 2026 · 14 min

Show notes

Friday, October 16, 2026 

In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover the FDA clearance of Motivista as the first prescription app for negative symptoms of schizophrenia. They break down the 16 week CONVOKE trial and what a 2.6 point edge over a control app means for stable patients on antipsychotics. They also review new ACP guidance placing menopausal hormone therapy first for hot flashes and night sweats, with second and third line options. Plus: they discuss early feasibility data on a medical AI chatbot for pre visit histories, new federal recommendations on concentrated kratom products, and more. 


Coverage Timeline:

(00:00) Intro 

(01:08) Schizophrenia App Cleared

(03:50) Hot Flashes Guidance

(04:47) Dogs & Sleep Study

(06:51) AI In Urgent Care

(08:37) Awards & Dahlias


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected]. 


Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources 


Medlines is a Human Content Production

All episodes of Medlines

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.